Regeneron Pharma (REGN) Posts Q1 Loss of $0.49, Wider than Views
Get Alerts REGN Hot Sheet
Price: $896.82 +0.32%
Revenue Growth %: +2.2%
Financial Fact:
Cost of goods sold: 29.9M
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: +2.2%
Financial Fact:
Cost of goods sold: 29.9M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q1 loss of ($0.49), $0.13 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $112.2 million versus the consensus estimate of $117.02 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regeneron Pharma (REGN) PT Raised to $1,099 at UBS
- Schlumberger (SLB) earnings in-line, revenue beats expectations
- Park National Corp. (PRK) Tops Q1 EPS by 36c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!